Doctor profile · Federal record
Dr. Fehmida Zahabi, MD
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Plano, TX
- NPI 1740397603
- Accepts Medicare
- 39 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6300 Stonewood Dr, Suite 412
Plano, TX 750245280
(469) 467-2478
fax (469) 467-8146 - Mailing address
-
Po Box 251607
Plano, TX 750255151
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- September 21, 2010
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Texas #K1736 · California #A55371
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740397603. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
12,992
Distinct HCPCS
8
Medicare allowed
$244,578
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,850 | 15 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 351 | 164 | $120 | |
36415 |
Insertion of needle into vein for collection of blood sample | 339 | 150 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 211 | 56 | $86 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 156 | 28 | $123 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 56 | 56 | $208 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 17 | 16 | $36 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 12 | 11 | $54 |
In context: peer comparison
Among 5 peers in Plano Rheumatology Physician, average services per provider: 1,354. This provider delivers 9.6× the peer median.Open Payments
Industry payments received
All-time total
$3,489
Transactions
168
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 24 | $627.66 | |
| GlaxoSmithKline, LLC. | 17 | $480.87 | |
| Ucb, INC. | 14 | $412.46 | |
| Amgen INC. | 26 | $338.10 | |
| AstraZeneca Pharmaceuticals Lp | 11 | $235.66 | |
| Pfizer INC. | 18 | $230.03 | |
| Novartis Pharmaceuticals Corporation | 21 | $176.63 | |
| Lilly USA, LLC | 8 | $172.55 | |
| Genzyme Corporation | 3 | $161.32 | |
| Fresenius Kabi USA, LLC | 9 | $140.84 | |
| Ani Pharmaceuticals, INC. | 6 | $133.85 | |
| Aurinia Pharma U.S., INC. | 5 | $83.72 | |
| Janssen Biotech, INC. | 1 | $77.99 | |
| Scilex Pharmaceuticals INC. | 3 | $49.15 | |
| Radius Health, INC. | 2 | $39.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
762
Patients
159
Total drug cost
$208,514
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 214 | 52 | $16,159 |
| Methotrexate (Methotrexate Sodium) | Brand | 109 | 30 | $5,226 |
| Leflunomide | Generic | 82 | 19 | $9,108 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 55 | 12 | $1,630 |
| Prednisone | Generic | 42 | 13 | $357 |
| Methylprednisolone | Generic | 41 | 22 | $413 |
| Celecoxib | Generic | 31 | 11 | $2,612 |
| Tramadol Hcl | Generic | 29 | 0 | $287 |
| Xeljanz Xr (Tofacitinib Citrate) | Brand | 29 | 0 | $171,069 |
| Omeprazole | Generic | 26 | 0 | $251 |
Frequently asked questions
What is Dr. Fehmida Zahabi's medical specialty?
Dr. Fehmida Zahabi practices Rheumatology Physician in Plano, TX.
Where does Dr. Fehmida Zahabi practice?
Dr. Fehmida Zahabi practices at 6300 Stonewood Dr, Plano, TX 750245280. Office phone: 4694672478.
What is Dr. Fehmida Zahabi's NPI?
Dr. Fehmida Zahabi's National Provider Identifier (NPI) is 1740397603, issued by NPPES.
Does Dr. Fehmida Zahabi accept Medicare assignment?
Yes. Dr. Fehmida Zahabi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Fehmida Zahabi commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Established patient office or other outpatient visit (HCPCS 99214); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.